This study showed that CD73 is highly expressed in pancreatic cancer, and the application of CRISPR/Cas9 technology to knockout of CD73 in human and murine cell lines can inhibit the proliferation and migration of tumor cells and induced G1 cell cycle arrest. This evidence concerns the gene NT5E and neoplasm.